GlaxoSmithKline Pakistan Limited (PSX: GLAXO)
Pakistan
· Delayed Price · Currency is PKR 174.25
+10.87 (6.65%)
At close: Sep 9, 2024
GlaxoSmithKline Pakistan Cash Flow Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | 533.95 | 2,463 | 5,354 | 3,375 | 3,041 | Upgrade
|
| Depreciation & Amortization | - | 932.3 | 859.38 | 775.27 | 761.5 | 809.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -82.76 | -124.62 | -633.9 | -17.21 | -44.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 6.01 | 18.02 | 15.54 | 30.81 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 160.34 | 89.7 | 42.74 | -30.5 | 44.03 | Upgrade
|
| Other Operating Activities | - | -703.15 | -431.51 | 1,204 | 679.82 | -596.06 | Upgrade
|
| Change in Accounts Receivable | - | 395.71 | -358.67 | -154.15 | -37.98 | 424.17 | Upgrade
|
| Change in Inventory | - | -2,256 | -3,363 | -1,077 | 180.77 | -435.85 | Upgrade
|
| Change in Accounts Payable | - | 4,043 | 2,827 | -36.69 | 956.95 | 369.6 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,386 | -5,142 | -512.05 | 30.39 | -1,021 | Upgrade
|
| Operating Cash Flow | - | 1,595 | -3,161 | 4,987 | 5,960 | 2,566 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -16.33% | 132.28% | -14.50% | Upgrade
|
| Capital Expenditures | - | -1,649 | -1,533 | -1,304 | -1,316 | -1,343 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 212.95 | 244.47 | 777.27 | 52.99 | 125.38 | Upgrade
|
| Other Investing Activities | - | 279.45 | 827.1 | 374.94 | 237.1 | 136.95 | Upgrade
|
| Investing Cash Flow | - | -1,157 | -461.6 | -151.56 | -1,026 | -1,081 | Upgrade
|
| Long-Term Debt Repaid | - | -25.59 | -14.6 | -11.46 | -12.09 | -8.09 | Upgrade
|
| Net Debt Issued (Repaid) | - | -25.59 | -14.6 | -11.46 | -12.09 | -8.09 | Upgrade
|
| Common Dividends Paid | - | -1,845 | -375.03 | -2,062 | -1,892 | -2,220 | Upgrade
|
| Financing Cash Flow | - | -1,871 | -389.63 | -2,073 | -1,904 | -2,228 | Upgrade
|
| Net Cash Flow | - | -1,433 | -4,012 | 2,762 | 3,031 | -742.96 | Upgrade
|
| Free Cash Flow | - | -54.23 | -4,694 | 3,683 | 4,644 | 1,223 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -20.69% | 279.89% | -43.05% | Upgrade
|
| Free Cash Flow Margin | - | -0.11% | -11.22% | 10.05% | 13.23% | 3.34% | Upgrade
|
| Free Cash Flow Per Share | - | -0.17 | -14.74 | 11.57 | 14.58 | 3.84 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 8.86 | 91.53 | Upgrade
|
| Cash Income Tax Paid | - | 2,309 | 2,639 | 871.59 | 810 | 2,121 | Upgrade
|
| Levered Free Cash Flow | - | -1,126 | -1,473 | 3,545 | 4,278 | 1,559 | Upgrade
|
| Unlevered Free Cash Flow | - | -1,122 | -1,470 | 3,549 | 4,282 | 1,618 | Upgrade
|
| Change in Net Working Capital | - | 1,633 | 3,964 | 218.77 | -1,768 | 855.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.